Zealand Pharma convenes its Annual General Meeting 2025
20 févr. 2025 07h00 HE
|
Zealand Pharma
Company Announcement – No. 3 / 2025 Zealand Pharma convenes its Annual General Meeting 2025 Notice to convene the Annual General Meeting 2025 of Zealand Pharma A/S (CVR no. 20 04 50 78) (the...
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
20 févr. 2025 04h08 HE
|
Zealand Pharma
Company announcement – No. 2 / 2025 Correction includes 2024 Annual Report attached in iXBRL format. Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with...
Zealand Pharma Announces Financial Results for the Full Year 2024
20 févr. 2025 01h00 HE
|
Zealand Pharma
Company announcement – No. 2 / 2025 Zealand Pharma Announces Financial Results for the Full Year 2024 A transformational year with significant clinical advancement across differentiated obesity...
Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results
13 févr. 2025 11h00 HE
|
Zealand Pharma
Press Release – No. 3 / 2025 Zealand Pharma conference call on February 20 at 2pm CET (8am ET) to present full year 2024 financial results Copenhagen, Denmark, February 13, 2025 – Zealand Pharma...
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
13 janv. 2025 11h00 HE
|
Zealand Pharma
Company announcement – No. 1 / 2025 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity
07 janv. 2025 11h00 HE
|
Zealand Pharma
Press Release – No. 2 / 2025 Steven R. Smith, MD, joins Zealand Pharma as Senior Global Medical Advisor in Obesity Copenhagen, Denmark, January 7, 2025 – Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL)...
Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th
06 janv. 2025 11h00 HE
|
Zealand Pharma
Press Release – No. 1 / 2025 Zealand Pharma to present at the 43rd Annual J.P. Morgan Healthcare Conference on January 13th Copenhagen, Denmark, January 6, 2025 – Zealand Pharma A/S (CVR-no....
Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons
25 déc. 2024 11h40 HE
|
Zealand Pharma
Company announcement – No. 53 / 2024 Transactions in Zealand Pharma shares and/or related securities by persons discharging managerial responsibilities and/or their closely associated persons ...
Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc.
25 déc. 2024 11h30 HE
|
Zealand Pharma
Company announcement – No. 52 / 2024 Zealand Pharma major shareholder announcement: The Capital Group Companies, Inc. Copenhagen, Denmark, 25 December 2024 – Zealand Pharma A/S (“Zealand”) (Nasdaq:...
U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome
19 déc. 2024 14h58 HE
|
Zealand Pharma
Company announcement – No. 51 / 2024 U.S. Food and Drug Administration issues Complete Response Letter for the glepaglutide New Drug Application for the treatment of short bowel syndrome The FDA...